» Articles » PMID: 34360916

Enzymatic Decontamination of G-Type, V-Type and Novichok Nerve Agents

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Aug 7
PMID 34360916
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Organophosphorus nerve agents (OPNAs) are highly toxic compounds inhibiting cholinergic enzymes in the central and autonomic nervous systems and neuromuscular junctions, causing severe intoxications in humans. Medical countermeasures and efficient decontamination solutions are needed to counteract the toxicity of a wide spectrum of harmful OPNAs including G, V and Novichok agents. Here, we describe the use of engineered OPNA-degrading enzymes for the degradation of various toxic agents including insecticides, a series of OPNA surrogates, as well as real chemical warfare agents (cyclosarin, sarin, soman, tabun, VX, A230, A232, A234). We demonstrate that only two enzymes can degrade most of these molecules at high concentrations (25 mM) in less than 5 min. Using surface assays adapted from NATO AEP-65 guidelines, we further show that enzyme-based solutions can decontaminate 97.6% and 99.4% of 10 g∙m of soman- and VX-contaminated surfaces, respectively. Finally, we demonstrate that these enzymes can degrade ethyl-paraoxon down to sub-inhibitory concentrations of acetylcholinesterase, confirming their efficacy from high to micromolar doses.

Citing Articles

Role of paraoxonase 1 in organophosphate G-series nerve agent poisoning and future therapeutic strategies.

Tripathy R, Khandave P, Bzdrenga J, Nachon F, Brazzolotto X, Pande A Arch Toxicol. 2024; 99(2):447-465.

PMID: 39356346 DOI: 10.1007/s00204-024-03884-2.


Applications of Microbial Organophosphate-Degrading Enzymes to Detoxification of Organophosphorous Compounds for Medical Countermeasures against Poisoning and Environmental Remediation.

Pashirova T, Salah-Tazdait R, Tazdait D, Masson P Int J Mol Sci. 2024; 25(14).

PMID: 39063063 PMC: 11277490. DOI: 10.3390/ijms25147822.


Changes in Active Site Loop Conformation Relate to the Transition toward a Novel Enzymatic Activity.

Jacquet P, Billot R, Shimon A, Hoekstra N, Bergonzi C, Jenks A JACS Au. 2024; 4(5):1941-1953.

PMID: 38818068 PMC: 11134384. DOI: 10.1021/jacsau.4c00179.


Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication.

Iyengar A, Khandave P, Bzdrenga J, Nachon F, Brazzolotto X, Pande A Protein Pept Lett. 2024; 31(5):345-355.

PMID: 38706353 DOI: 10.2174/0109298665284293240409045359.


Novichok Nerve Agents as Inhibitors of Acetylcholinesterase-In Silico Study of Their Non-Covalent Binding Affinity.

Madaj R, Gostynski B, Chworos A, Cypryk M Molecules. 2024; 29(2).

PMID: 38257251 PMC: 10819560. DOI: 10.3390/molecules29020338.


References
1.
Chai P, Hayes B, Erickson T, Boyer E . Novichok agents: a historical, current, and toxicological perspective. Toxicol Commun. 2018; 2(1):45-48. PMC: 6039123. DOI: 10.1080/24734306.2018.1475151. View

2.
Bigley A, Mabanglo M, Harvey S, Raushel F . Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR. Biochemistry. 2015; 54(35):5502-12. DOI: 10.1021/acs.biochem.5b00629. View

3.
Taysse L, Daulon S, Delamanche S, Bellier B, Breton P . Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine. Hum Exp Toxicol. 2007; 26(2):135-41. DOI: 10.1177/0960327107071866. View

4.
Bigley A, Xu C, Henderson T, Harvey S, Raushel F . Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis. J Am Chem Soc. 2013; 135(28):10426-32. PMC: 3747228. DOI: 10.1021/ja402832z. View

5.
Masson P . Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett. 2011; 206(1):5-13. DOI: 10.1016/j.toxlet.2011.04.006. View